Phenelzine Sulfate is a potent, irreversible monoamine oxidase inhibitor (MAOI) indicated for the treatment of major depressive disorder, obsessive-compulsive disorder, and atypical depression. By non-selectively… Read more
Phenelzine Sulfate is a potent, irreversible monoamine oxidase inhibitor (MAOI) indicated for the treatment of major depressive disorder, obsessive-compulsive disorder, and atypical depression. By non-selectively inhibiting MAO-A and MAO-B enzymes, this antidepressant increases synaptic concentrations of key neurotransmitters, including serotonin, norepinephrine, and dopamine. Laboratories rely on high-quality reference standards of the active pharmaceutical ingredient, along with its related impurities and metabolites, to ensure precise analytical results. Impurity profiling is critical for identifying potential synthesis by-products, such as N-phenethylnitrous hydrazide, which must be monitored to meet regulatory specifications. Furthermore, stable isotope labelled compounds are indispensable internal standards for accurate quantification using mass spectrometry. Access to these specialized materials supports robust method validation and rigorous quality control protocols throughout the pharmaceutical development and manufacturing process.